Results 61 to 70 of about 115,630 (250)

Synchronous unilateral parotid neoplasms. : a case report [PDF]

open access: yes, 2009
The parotid gland is the most usual location of benign neoplasms affecting major salivary glands and quite often the recurrence of these tumours is noticed, specially in the case of pleomorphic adenoma. The occurrence of multiple tumours in the parotid
Gallana Alvarez, Silvia   +3 more
core  

Myoepithelioma of the Parotid Gland: A Case Report with Review of the Literature and Classic Histopathology

open access: yesCase Reports in Otolaryngology, 2017
Myoepithelioma is a rare salivary gland neoplasm. They most commonly affect the major and minor salivary glands with the parotid gland being the most common, approximately 40%. Only 1% of all salivary gland neoplasms are myoepitheliomas.
Mark Weitzel   +2 more
doaj   +1 more source

A Rare Case of Lymphoepithelial Carcinoma of Salivary Gland in a Patient of Indian Origin [PDF]

open access: yesNational Journal of Laboratory Medicine, 2015
Salivary gland neoplasms comprise 3% of all the head and neck neoplasms. Lymphoepithelial carcinoma of the salivary gland is extremely rare and accounts for less than 1% of all salivary gland neoplasms.
Hemalatha A. L   +4 more
doaj   +1 more source

Stereotactic Body Radiotherapy (SBRT) of Previously Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma (SCC)

open access: yesHead &Neck, EarlyView.
ABSTRACT Purpose To evaluate the efficacy and safety of stereotactic body radiation therapy (SBRT) in previously untreated primary mucosal head and neck cancer (HNC) patients unfit for conventional radiation therapy. Materials and Methods Retrospective analysis of previously unirradiated primary SCC mucosal HNC patients treated with SBRT from 2011 to ...
Mohammed Aldohan   +10 more
wiley   +1 more source

Synchronous sebaceous lymphadenoma with squamous cell carcinoma – case report

open access: yesWorld Journal of Surgical Oncology, 2003
Background Sebaceous lymphadenoma is a rare benign salivary gland tumour of uncertain histogenesis. So is synchronous occurrence of two benign or malignant neoplasms.
Panicker Sathibai, Shukla Mridula
doaj  

Primary Malignant Parotid Lymphoma: Two Case Reports with Different Disease Progression and Treatment

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2011
Objective: To describe our experience in managing two cases of primary malignant parotid lymphoma.   Methods: Design: Case Report Setting: Tertiary University Referral Center Patients: Two   Results: Both patients underwent ...
Noor Dina Hashim   +5 more
doaj   +1 more source

Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy

open access: yesHead &Neck, EarlyView.
ABSTRACT Background To evaluate botulinum toxin type A (BoNT‐A) for First Bite Syndrome (FBS) and assess a symptom‐guided “Follow‐the‐Pain” (FTP) injection strategy in patients with incomplete response to standard treatment. Methods Consecutive patients with postoperative FBS were treated with ultrasound‐guided intraparotid BoNT‐A injection.
Rosario Marchese‐Ragona   +5 more
wiley   +1 more source

Neoadjuvant Cemiplimab for Resectable Locoregionally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series

open access: yesHead &Neck, EarlyView.
ABSTRACT Introduction A Phase II trial demonstrated that neoadjuvant cemiplimab was associated with pathologic complete response (pCR) in 51% of patients with locoregionally advanced cutaneous squamous cell carcinoma (cuSCC). We evaluated real‐world radiographic and pathologic responses to neoadjuvant cemiplimab and assessed radiologic–pathologic ...
Whitney Jin   +14 more
wiley   +1 more source

CYLD Cutaneous Syndrome and Associated Salivary Gland Pathology: A Systematic Review

open access: yesOTO Open
Objective To characterize salivary gland pathology and neoplasms associated with CYLD cutaneous syndrome, including location, risk of malignancy, and management practices. Data Sources MEDLINE Ovid, Embase, Cochrane CENTRAL, and Scopus.
Jane Y. Tong   +4 more
doaj   +1 more source

Early Postoperative Adverse Events (≤ 30 Days) in Spinal Oncology: Defining the Incidence, Severity, and Predictors in a Mixed Prospective Cohort Including Intradural and Metastatic Spinal Tumors

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Complication reporting in spinal tumor surgery remains inconsistently defined. We aimed to quantify the incidence, severity, and spectrum of early (≤ 30 days) postoperative adverse events (AEs) in spinal tumor surgery and to identify predictors of overall and serious complications using standardized severity grading.
Meltem Ivren   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy